Factors associated with non-compliance with hormone therapy cessation before screening mammography

References

• Boudreau DM, Buist DS, Rutter CM, Fishman PA, Beverly KR, Taplin S. Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography. Med Care 2006;44:62–9
   PubMed Web of Science ®Google Scholar
• Harvey JA, Pinkerton JV, Herman CR. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 1997;89:1623–5
   PubMed Web of Science ®Google Scholar
• Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042–50
   PubMed Web of Science ®Google Scholar
• Newton KM, Buist DS, Yu O, et al. Hormone therapy initiation after the Women's Health Initiative. Menopause 2008;15:487–93
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Buist DS, Anderson ML, Reed SD, et al. Short-term hormone therapy suspension and mammography recall: a randomized trial. Ann Intern Med 2009;150:752–65
   PubMed Web of Science ®Google Scholar
• Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081–7
   PubMed Web of Science ®Google Scholar
• Wiklund I, Holst J, Karlberg J, et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 1992;14:211–24
   PubMed Web of Science ®Google Scholar
• Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials. Selecting quality-of- life measures. Control Clin Trials 1991;12:204–16S
   PubMedGoogle Scholar
• Lee KA. Self-reported sleep disturbances in employed women. Sleep 1992;15:493–8
   PubMed Web of Science ®Google Scholar
• Reed SD, Buist DS, Anderson ML, et al. Short-term (1–2 mo) hormone therapy cessation before mammography. Menopause 2009;16:1125–31
   PubMed Web of Science ®Google Scholar
• Newton K, LaCroix A, Leveille S, Rutter C, Keenan N, Anderson L. Women's beliefs and decisions about hormone replacement therapy. J Womens Health 1997;6:459–65
   PubMed Web of Science ®Google Scholar
• Buist DS, LaCroix AZ, Newton KM, Keenan NL. Are long-term hormone replacement therapy users different from short- term and never users? Am J Epidemiol 1999;149:275–81
   PubMed Web of Science ®Google Scholar
• Hunter M, O'Dea I, Britten N. Decision-making and hormone replacement therapy: a qualitative analysis. Soc Sci Med 1997;45:1541–8
   PubMed Web of Science ®Google Scholar
• Kaufert P, Boggs P, Ettinger B, Woods N, Utian W. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197–202
   PubMed Web of Science ®Google Scholar
• Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 2000;7:273–81
   PubMed Web of Science ®Google Scholar
• Collins A, Landgren BM. Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women. Maturitas 1997;28:1–9
   PubMed Web of Science ®Google Scholar
• Appling S, Paez K, Allen J. Ethnicity and vasomotor symptoms in postmenopausal women. J Womens Health (Larchmt) 2007;16:1130–8
   PubMed Web of Science ®Google Scholar
• NAMS. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of the North American Menopause Society. Menopause 2007;14:168–82
   PubMed Web of Science ®Google Scholar
• Reynolds RF, Walker AM, Obermeyer CM, Rahman O, Guilbert D. Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO. J Clin Epidemiol 2001;54:1056–64
   PubMed Web of Science ®Google Scholar
• Connelly MT, Richardson M, Platt R. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990–1995. J Gen Intern Med 2000;15:542–50.
   PubMed Web of Science ®Google Scholar
• Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1–6
   PubMed Web of Science ®Google Scholar
• Hill DA, Weiss NS, LaCroix AZ. Adherence to postmenopausal hormone therapy during the year after the initial prescription: a population-based study. Am J Obstet Gynecol 2000;182:270–6
   PubMed Web of Science ®Google Scholar
• Brett KM, Madans J. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536–45
   PubMed Web of Science ®Google Scholar
• Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225–32
   PubMed Web of Science ®Google Scholar
• Schonberg MA, Davis RB, Wee CC. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Womens Health Issues 2005;15:187–95
   PubMed Web of Science ®Google Scholar